Stereochemical Discrimination at Organic Crystal Surfaces 1: The Systems Serine/Threonine and Serine/Allothreonine

The stereoselective interactions in aqueous solution between the crystal faces of centrosymmetric (R,S) serine 1 and additives resolved and racemic threonine 2 and allothreonine 3 were studied by four independent techniques: change in crystal habit on growth, anisotropic distribution of occluded additive during the crystal growth, etch pit formation on partial dissolution and atom-atom potential energy calculations. The effects of the two diastereomers 2 and 3 are radically different due to differences in adsorption: threonine is adsorbed on the {011} crystal faces; the (R) enantiomer is adsorbed at, and eventually occluded through the (011) and (011) crystal faces replacing an (R) serine molecule. By symmetry, (S) threonine is adsorbed and occluded through the enantiotopic (011) and (011) faces replacing (S) serine. In contrast, (R) and (S) allothreonine are both adsorbed primarily at the (100) and (100) faces. The results indicate that the serine moiety of adsorbed threonine and allothreonine assume the same conformation and position as the substrate molecule. The additive is adsorbed only at specific sites such that the C_β-CH₃ groups emerge from the crystal surface. The observed effects lead in the case of threonine, but not allothreonine, to the assignment of its absolute configuration.     

Specific glucocorticoid receptor in the iris--ciliary body of the rabbit

The cytoplasm of the iris--ciliary body of the rabbit contains a receptor capable of specifically binding dexamethasone. This binding protein has a high affinity for dexamethasone (average KD = 2.0 X 10(-8) M), a low capacity (average 4.8 X 10(-13) mol of steroid bound per milligram of protein), and extreme heat sensitivity; it exhibits a pattern of competition virtually identical to that obtained with glucocorticoid receptors from other tissues and shows characteristic physicochemical behavior in various salt concentrations. The demonstration of a specific dexamethasone receptor in the iris--ciliary body provides the first direct biochemical evidence that these tissues may function as a target organ for glucocorticoids.     

A Simple Technique for Enhancing the Hypothesis Testing Capability of Devices Sensitive to Phase in the Presence of Narrow-Band Normal Noise

A new statistic is described for hypothesis testing on phase in the presence of narrow-band normal noise when the true phase, itself, is a nonuniformly distributed random variable. Comparisons are made with the more standard direct techniques.     

Exploiting nonacoustic sensors for speech encoding

The intelligibility of speech transmitted through low-rate coders is severely degraded when high levels of acoustic noise are present in the acoustic environment. Recent advances in nonacoustic sensors, including microwave radar, skin vibration, and bone conduction sensors, provide the exciting possibility of both glottal excitation and, more generally, vocal tract measurements that are relatively immune to acoustic disturbances and can supplement the acoustic speech waveform. We are currently investigating methods of combining the output of these sensors for use in low-rate encoding according to their capability in representing specific speech characteristics in different frequency bands. Nonacoustic sensors have the ability to reveal certain speech attributes lost in the noisy acoustic signal; for example, low-energy consonant voice bars, nasality, and glottalized excitation. By fusing nonacoustic low-frequency and pitch content with acoustic-microphone content, we have achieved significant intelligibility performance gains using the DRT across a variety of environments over the government standard 2400-bps MELPe coder. By fusing quantized high-band 4-to-8-kHz speech, requiring only an additional 116 bps, we obtain further DRT performance gains by exploiting the ear's insensitivity to fine spectral detail in this frequency region.     

Oxidation of High-Melting Organic Compounds by Potassium Chlorate

The oxidation of anthracene, 9,9′-bianthryl and 1,1,2,2-tetraphenyl- 1,2-bis (9,10-dihydro-anthracenyl-9) ethane (TPDAE) by potassium chlorate and perchlorate, in the presence of vanadium pentoxide, was studied both by a batch method in closed ampoules and by gravimetry. The reactions took place with the participation of the gaseous phase while certain stages seem to be solid-solid processes.     

The demographics and politics of economic decline in New York City

New York City's economy has been declining since 1969. Although this decline is usually discussed with reference to interregional shifts in population and the migration of industry to the South and West, the root causes can be best understood in terms of the changing demographic, political and economic matrix of the City combined with short-sighted public policies toward business development.After explaining some important aspects of the political economy of economic erosion in New York City, the paper suggests several local government policy alternatives that might help to reverse the tide of economic decline.     

Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level

Oral pulse therapy with vitamin D is effective in suppressing parathyroid hormone (PTH) secretion in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism (2'hpt). However, this treatment often leads to hypercalcemia. The goals of the study were: (1) to examine whether the incidence of hypercalcemia decreases when dialysate calcium is reduced from 1.25 to 1.0 mmol/L; (2) to determine the relative role of the factors involved in the pathogenesis of hypercalcemia; and (3) to study the efficacy of a low oral pulse dose of alfacalcidol in preventing the recurrence of 2'hpt. Fourteen continuous ambulatory peritoneal dialysis patients with 2'hpt were treated with pulse oral alfacalcidol and calcium carbonate and dialyzed with a 1.0-mmol (n = 7) or a 1.25-mmol (n = 7) dialysate calcium. The response rate (87%) and the incidence (71%) and severity of hypercalcemia were similar in both groups. In the early response stage, PTH decreased by 70% in both groups, and serum ionized calcium (iCa) increased from 1.18 +/- 0.02 to 1.27 +/- 0.04 mmol/L (P < 0.005) in the 1.0 group and from 1.19 +/- 0.02 to 1.29 +/- 0.02 mmol/L in the 1.25 group (P < 0.005). Nine of the 12 responders had a further decrease in serum PTH, which was associated with an additional increase in iCa from 1.28 +/- 0.02 to 1.47 +/- 0.04 (P < 0.005). Multivariate analysis showed that the early increase in iCa was positively correlated with alfacalcidol dosage (r = 0.69). In contrast, the late increase in iCa was mostly accounted for by the decrease in serum PTH (r = -0.93). This occurred while calcium carbonate, alfacalcidol dosage, and serum 1,25 hydroxy D3 remained unchanged compared with the early response stage. Finally, an alfacalcidol dose of 1 microg twice weekly was unable to maintain serum PTH at an adequate level in the long term. These data show that a reduction in dialysate calcium from 1.25 to 1.0 mmol does not reduce the occurrence of hypercalcemia and suggest that lowering serum PTH reduces the ability of the bone to handle a calcium load within a few weeks, thus causing hypercalcemia.     

Effect of brain, body, and magnet bore temperatures on energy metabolism during global cerebral ischemia and reperfusion monitored by magnetic resonance spectroscopy in rats

To record brain temperature for comparison with rectal and temporalis muscle temperatures in preliminary studies before MR spectroscopy experiments, a thermistor was inserted into the basal ganglia in eight anesthetized, ventilated, and physiologically monitored rats. The rats were placed in an MR spectrometer and subjected to 60 min of global cerebral ischemia and 2 h of reperfusion without radiofrequency (RF) pulsing. Body temperature was maintained at 37.5-38.0 degrees C (normothermia) or 36.5-37.0 degrees C (mild hypothermia). Brain temperature during ischemia, which dropped to 31.9 +/- 0.3 (hypothermia) and 33.6 +/- 0.5 degrees C (normothermia), correlated with temporalis muscle temperature (r2 = 0.92) but not with body or magnet bore temperature measurements. Ischemia reduced brain temperature approximately 1.7 degrees C in rats subjected to mild hypothermia (1 degree reduction of body temperature). Parallel MR spectroscopy experiments showed no significant difference in energy metabolites between normothermic and hypothermic rats during ischemia. However, the metabolic recovery was more extensive 20-60 min after the onset of reperfusion in hypothermic rats, although not thereafter (P < 0.05). Mild hypothermia speeds metabolic recovery temporarily during reperfusion but does not retard energy failure during global ischemia in rats.     

Adult onset Krabbe''s leukodystrophy

Benign mesenchymal tumours of the bladder are rare, accounting for only 1-5% of bladder neoplasms. We describe what appears to be the first reported case of massive bleeding from a leiomyoma of the urinary bladder causing tamponade requiring emergency surgery.     

Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis

BACKGROUND: Chronic myelogenous leukemia (CML) is an indolent but ultimately fatal disease. Because the natural history of CML varies and quality of life with CML may be excellent until shortly before death, deciding whether and when to pursue unrelated donor bone marrow transplantation is often difficult. OBJECTIVE: To compare early transplantation, delayed transplantation, and no transplantation for patients with chronic-phase CML on the basis of discounted, quality-adjusted life expectancy. DESIGN: A markov model comparing different strategies was constructed. This model considers patient age, quality of life, risk aversion, and the competing risks for CML progression and transplant toxicity. SETTING: Therapeutic decision at the time of diagnosis of CML. PATIENTS: The base case is a 35-year-old patient with intermediate-prognosis CML. Younger and older patients with better and worse prognoses are also evaluated. INTERVENTION: Early transplantation, delayed transplantation, and no transplantation. MEASUREMENTS: Quality-adjusted, discounted life expectancy. RESULTS: For patients with newly diagnosed CML, transplantation within the first year provides the greatest quality-adjusted expected survival, although this benefit decreases with increasing patient age. For a 35-year-old patient with intermediate-prognosis CML, transplantation within the first year results in 53 more discounted, quality-adjusted years of life expectancy than does no transplantation. This finding is robust even with varying baseline assumptions. CONCLUSIONS: These results support the use of early unrelated donor bone marrow transplantation for most patients with CML.